Pekka Taimen

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer.

Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 09, 2026

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.

Journal: Scandinavian journal of urology

Published: February 11, 2026

Corrigendum to "Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer" [Clin. Chim. Acta 582 (2026) 120790].

Corrigendum to "Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer" [Clin. Chim. Acta 582 (2026) 120790].

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: January 04, 2026

Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).

Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).

Journal: Journal of molecular medicine (Berlin, Germany)

Published: December 04, 2025

Corrigendum to Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

Corrigendum to Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

Journal: The Journal of clinical investigation

Published: December 01, 2025

Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer.

Aberrantly glycosylated PSMA in urine as a potential marker for prostate cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 26, 2025

Proof-of-concept PET imaging of pulmonary sarcoidosis using VAP-1-targeted radiotracer [68Ga]Ga-DOTA-Siglec-9.

Proof-of-concept PET imaging of pulmonary sarcoidosis using VAP-1-targeted radiotracer [68Ga]Ga-DOTA-Siglec-9.

Journal: Respiratory research

Published: June 28, 2025

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study.

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study.

Journal: BJU international

Published: May 28, 2025

Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer.

Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer.

Journal: The Journal of pathology

Published: March 13, 2025

Digitalization of pathology in a multicenter setup: A user experience study and comparison of two alternative implementation strategies.

Digitalization of pathology in a multicenter setup: A user experience study and comparison of two alternative implementation strategies.

Journal: Pathology, research and practice

Published: February 10, 2025

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 02, 2025

High-Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle-Based Lateral Flow Immunoassay.

High-Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle-Based Lateral Flow Immunoassay.

Journal: Journal of extracellular biology

Published: December 20, 2024

Showing 1-12 of 133

Last Updated: 09/26/2026